首页> 外文OA文献 >Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer

【2h】

Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer

机译：ALK基因重排非小细胞肺癌的临床和计算断层扫描特性：与EGFR突变和ALK / EGFR阴性肺癌的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mio Mori; Hideyuki Hayashi; Minoru Fukuda; Sumihisa Honda; Takeshi Kitazaki; Kazuto Shigematsu; Naohiro Matsuyama; Mayumi Otsubo; Takeshi Nagayasu; Mikiko Hashisako; Kazuhiro Tabata; Masataka Uetani; Kazuto Ashizawa;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer [J] . Mio Mori, Hideyuki Hayashi, Minoru Fukuda, Thoracic cancer. . 2019,第4期

机译：ALK基因重排非小细胞肺癌的临床和计算断层扫描特性：与EGFR突变和ALK / EGFR阴性肺癌的比较
2. Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib [J] . Zhao Yiming, Wang Shuyuan, Zhang Bo, Targeted oncology . 2019,第2期

机译：非小细胞肺癌的临床管理，伴随着EGFR突变和ALK重排：EGFR酪氨酸激酶抑制剂和克里齐替尼的疗效
3. Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK -rearranged non–small–cell lung cancer harbored coexisting EGFR mutation [J] . Akihiko Miyanaga, Kumi Shimizu, Rintaro Noro, BMC Cancer . 2013,第1期

机译：EGFR酪氨酸激酶和ALK抑制剂对EML4–ALK重排的非小细胞肺癌具有EGFR突变的活性
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer [O] . Mio Mori, Hideyuki Hayashi, Minoru Fukuda, 2019

机译：具有ALK基因重排的非小细胞肺癌的临床和计算机断层扫描特征：与EGFR突变和ALK / EGFR阴性肺癌的比较
7. Lung Cancers with Concomitant EGFR Mutations and ALK Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation [O] . Jin-Ji Yang, Xu-Chao Zhang, Jian Su, 2014

机译：具有伴随的EGFR突变和ALK重排的肺癌：对EGFR-TKI和CRIZOTINIB的不同反应与不同的受体磷酸化相关

Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer

著录项

引文网络

相似文献

相关主题

期刊订阅